Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-031718

Options or other derivatives

  • CEO acquired 45,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Grant or award : show line 1 in the form Series D-1 Convertible Preferred Stock +45,860 2,866,761 D
Loading xslF345X06/ownership.xml…